“…Immunohistochemical (IHC) staining, which can detect one tumour cell among 10 000–100 000 normal cells, more clearly delineates target tumour cells from surrounding lymphoid follicular cells than does H&E staining, thus facilitating the pathologist’s task of detecting tumour cells [47]. These techniques have been used to detect nodal disease in breast, cervical and prostate cancers, showing sensitivities greater than or equal to standard pathological evaluation [48–53]. A modification of reverse transcriptase‐PCR (RT‐PCR), real‐time quantitative PCR (qPCR), has replaced PCR to serve as the basic technique used by several investigators for detecting nodal disease [54,55].…”